Heparin-poly(ethylene glycol)-poly(vinyl alcohol) hydrogel: preparation and assessment of thrombogenicity

journal article·1992

Gerard R. Llanos, Michael V. Sefton

Biomaterials· Volume 13· Issue 7

Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

OpenAlex topics: Venous Thromboembolism Diagnosis and Management · Peripheral Artery Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Show source-provided references

2. Interaction between blood components and hydrogels with poly(oxyethylene) chains

3. Polyethylene oxide as a biomaterial

4. Preparation of nonthrombogenic materials by chemical modification

5. Effect of heparin-PVA hydrogel on platelets in a chronic canine arterio-venous shunt10.1002/jbm.820230404 ↗

6. Immobilization of polyethylene glycol) onto a poly(vinyl alcohol) hydrogel. 2: Evaluation of thrombogenicity

7. Immobilization of poly(ethylene glycol) onto a poly(vinyl alcohol) hydrogel. 1: Synthesis and characterization10.1021/ma00023a003 ↗

8. Poly(dimethylsiloxane)-Poly(ethylene oxide)-heparin Block Copolymers. 1. Synthesis and Characterization10.1002/jbm.820220307 ↗

9. Platelet consumption by polyvinyl alcohol coated tubing in canines10.1002/jbm.820250707 ↗

10. Platelet malondialdehyde production kinetics after cyclooxygenase block: a study performed with a modified high sensitivity assay

11. Heparin immobilization onto segmented polyurethaneurea surfaces — effect of hydrophilic spacers10.1002/jbm.820221103 ↗

12. Evaluation of blood compatibility of PEO grafted and heparin immobilized polyurethanes

13. A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue

14. The platelet aggregating effect of eight commercial heparins10.1111/j.1600-0609.1972.tb00973.x ↗

15. In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis